SCHEMBL8823144

SCHEMBL8823144

CN(C)c1ccccc1.CNc1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 5/20 0.67
▸ ALDH1A1 P00352 5/20 0.46
▸ HSD17B10 Q99714 3/20 0.46
▸ ALOX15 P16050 2/20 0.46
▸ TDP1 Q9NUW8 4/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ RELA Q04206 1/20 0.45
▸ KCNK3 O14649 1/20 0.43
▸ ADRA2A P08913 1/20 0.43
▸ KDM1A O60341 2/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ HPGD P15428 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ CYP3A4 P08684 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ MAPT P10636 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL22658153 0.85 ALDH1A1 (0.56) TSHRALDH1A1HSD17B10ALOX15TDP1
Diphenylamine SCHEMBL11871615 0.83 HSD17B10 (0.60) TSHRALDH1A1HSD17B10ALOX15TDP1
SCHEMBL146321 0.82 ALDH1A1 (0.61) TSHRALDH1A1HSD17B10ALOX15TDP1
SCHEMBL11786719 0.82 TSHR (0.61) TSHRALDH1A1HSD17B10ALOX15TDP1
SCHEMBL8277 0.82 — —
SCHEMBL19298582 0.82 TSHR (1.00) TSHRALDH1A1HSD17B10ALOX15TDP1
SCHEMBL21208167 0.82 ALDH1A1 (0.67) TSHRALDH1A1HSD17B10ALOX15TDP1
Benzene SCHEMBL17977991 0.82 TSHR (1.00) TSHRALDH1A1HSD17B10ALOX15TDP1
SCHEMBL7879117 0.82 — —
SCHEMBL3008675 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0786466-A1 Transition metal compound, olefin polymerization catalyst comprising the compound, and process for production of olefin polymer Tosoh Corporation (JP) 1997-07-30 — — EP disclosed
US-RE32992-E THERAPY FOR INFECTIOUS DISEASES CAUSED BY PATHOGENIC MICROORGANISMS Fujisawa Pharaceutical Co., Ltd. (JP) 1989-07-18 — — US disclosed
US-4801580-A Peptide, process for preparation thereof and use thereof FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1989-01-31 — — US disclosed
US-4749691-A Peptide, process for preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-06-07 — — US disclosed
US-4725582-A IMMUNE RESPONSE ENHANCERS FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1988-02-16 — — US disclosed
EP-0025842-B1 PEPTIDES, PROCESS FOR THEIR PREPARATION, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR INTERMEDIATES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-06-03 — — EP disclosed
US-4576753-A MICROBIOCIDES, ANTIBIOTICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-03-18 — — US disclosed
US-4539152-A INTERMEDIATES FOR THIENAMYCIN ANTIBIOTICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-09-03 — — US disclosed
EP-0057412-B1 PEPTIDE, PROCESS FOR PREPARATION THEREOF AND USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-05-22 — — EP disclosed
US-4512980-A IMMUNOLOGICALLY EFFECTIVE FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 1985-04-23 — — US disclosed
US-4399277-A 7-Amino-3-phosphonocephalosporanic acid compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-08-16 — — US disclosed
US-4383945-A 4-Substituted-2-oxoazetidine compounds and processes for the preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-05-17 — — US disclosed
EP-0057412-A1 Peptide, process for preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1982-08-11 — — EP disclosed
US-4311640-A ANTIBIOTIC FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1982-01-19 — — US disclosed
US-4304718-A ANTIBIOTICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-12-08 — — US disclosed
EP-0035689-A1 4-Substituted-2-oxoazetidine compounds, processes for their preparation, and their use for preparing antibiotics FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-09-16 — — EP disclosed
EP-0027260-A2 Peptides, processes for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-04-22 — — EP disclosed
EP-0025842-A2 Peptides, process for their preparation, their pharmaceutical compositions and their intermediates FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-04-01 — — EP disclosed
US-4181800-A ANTIBIOTICS FROM SUBSTITUTED PERHYDRO-S-TRIAZINES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-01-01 — — US disclosed
US-4150054-A CONTACTING WITH ALCOHOL IN PRESENCE OF PHOSPHORIC ACID AND SALTS OF THE ALIPHATIC AMINO COMPOUND BAYER AKTIENGESELLSCHAFT (DE) 1979-04-17 — — US disclosed
Send feedback